Revance is a fully integrated aesthetics, skincare, and therapeutics company built on more than 25 years of science-led development, tracing back to its 1999 founding as Essentia Biosystems and brought together with Crown Laboratories through their 2025 combination. Revance’s portfolio includes an FDA-approved neuromodulator, dermal fillers, SkinPen Precision ELITE, MicroPenEVO, and Biojuve portfolio.

SkinPen Precision Elite is a percutaneous microneedling system from Revance Aesthetics, designed to improve skin texture, reduce the appearance of acne scarring, and support overall skin rejuvenation. The system uses single-use cartridges with digital recognition for traceable, single-patient use, combined with ActiSine™️ technology for active needle retraction and a handpiece validated for protection against fluid ingress. Precise depth control, from 0.25 mm to 2.5 mm, allows practitioners to tailor each treatment to the specific skin concern and treatment area.

MicroPen EVO is an advanced automated microneedling device, built for professional aesthetic practices that need a fast, reliable platform for everyday treatments. The cordless, ergonomic device runs on a lithium-ion battery with more than four hours of runtime, paired with sterile, single-use cartridges with adjustable needle depth for precise, customizable treatments. A snap-on cartridge connection allows for fast changes between patients, while a Teflon seal is designed to reduce the risk of fluid ingress into the handpiece.

BioJuve is a Living Skin Biome Care line, built around pre-, pro-, and postbiotic ingredients designed to support the skin’s own microbiome rather than work against it. The BioJuve routine is formulated for use morning and night, helping the skin recover and stay hydrated between in-clinic procedures. BioJuve is designed to complement treatments such as microneedling, extending their results through a daily skincare routine built specifically around skin biome health.